AU2002216613A1 - Us0130034idic tryptase substrates and assay for tryptase activity using same - Google Patents

Us0130034idic tryptase substrates and assay for tryptase activity using same

Info

Publication number
AU2002216613A1
AU2002216613A1 AU2002216613A AU1661302A AU2002216613A1 AU 2002216613 A1 AU2002216613 A1 AU 2002216613A1 AU 2002216613 A AU2002216613 A AU 2002216613A AU 1661302 A AU1661302 A AU 1661302A AU 2002216613 A1 AU2002216613 A1 AU 2002216613A1
Authority
AU
Australia
Prior art keywords
tryptase
seq
substrates
assay
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002216613A
Inventor
Charles S Craik
Mary Haak-Frendscho
Jennifer L. Harris
Andrew L. Niles
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Promega Corp
Original Assignee
Promega Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Promega Corp filed Critical Promega Corp
Publication of AU2002216613A1 publication Critical patent/AU2002216613A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The invention is directed to synthetic polypeptide substrates for tryptase enzymes and assays for tryptase activity that utilize the synthetic polypeptide substrates. The preferred synthetic polypeptide substrates are tetramers of the formula P4-P3-P2-P1, wherein the substrate is selected from the group consisting of P-R-N-K (SEQ. ID. NO: 2), P-K-N-K (SEQ. ID. NO: 3), P-R-N-R (SEQ. ID. NO: 4), P-K-N-R (SEQ. ID. NO: 5), P-A-N-K (SEQ. ID. NO: 6), and P-R-T-K (SEQ. ID. NO: 7).
AU2002216613A 2000-10-27 2001-10-03 Us0130034idic tryptase substrates and assay for tryptase activity using same Abandoned AU2002216613A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24401300P 2000-10-27 2000-10-27
US60/244,013 2000-10-27
US09/955,639 US6797461B2 (en) 2000-10-27 2001-09-19 Tryptase substrates and assay for tryptase activity using same
US09/955,639 2001-09-19
PCT/US2001/030984 WO2002034765A2 (en) 2000-10-27 2001-10-03 us0130034IDIC TRYPTASE SUBSTRATES AND ASSAY FOR TRYPTASE ACTIVITY USING SAME

Publications (1)

Publication Number Publication Date
AU2002216613A1 true AU2002216613A1 (en) 2002-05-06

Family

ID=26936256

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002216613A Abandoned AU2002216613A1 (en) 2000-10-27 2001-10-03 Us0130034idic tryptase substrates and assay for tryptase activity using same

Country Status (6)

Country Link
US (1) US6797461B2 (en)
EP (1) EP1358205B1 (en)
AT (1) ATE331729T1 (en)
AU (1) AU2002216613A1 (en)
DE (1) DE60121225T2 (en)
WO (1) WO2002034765A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100109969A (en) * 2002-10-02 2010-10-11 카탈리스트 바이오사이언시즈, 인코포레이티드 Methods of generating and screening for proteases with altered specificity
US7416854B2 (en) * 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
EP2445517B1 (en) 2009-06-25 2014-07-30 Nestec S.A. Methods for diagnosing irritable bowel syndrome
CN114341154B (en) * 2019-09-05 2024-07-30 国立大学法人东京农工大学 Substrate for measuring tryptase activity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL60888A (en) * 1978-06-16 1984-07-31 Yeda Res & Dev Substrates and process for the quantitative assay of enzymes
DE2945239A1 (en) * 1979-11-09 1981-05-21 Troponwerke GmbH & Co KG, 5000 Köln Antiinflammatory oligopeptide derivs. for e.g., rheumatism - contg. protected amino acid gp., attached to a lysine-proline-arginine tri:peptide chain
SE453510B (en) * 1980-12-29 1988-02-08 Toyo Jozo Kk PEPTIME FOR ANALYSIS OF HUMANT PARATYROID HORMON
US4390528A (en) 1981-11-16 1983-06-28 Research Corporation Tuftsinyl-tuftsin
US5391705A (en) 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
US5589458A (en) * 1992-11-13 1996-12-31 Thomas Jefferson University Compounds that inhibit T cell proliferation and methods for using the same
GB2324529A (en) 1997-02-21 1998-10-28 Merck & Co Inc A combinatorial library based on a tetrapeptide substituted with aminomethylcoumarin for characterizing proteases
EP0980440B1 (en) * 1997-05-01 2007-08-01 Minnesota Mining And Manufacturing Company Fluorogenic protease substrates based on dye-dimerization
SK10742001A3 (en) * 1999-01-27 2002-08-06 Ortho-Mcneil Pharmaceutical, Inc. Peptidyl heterocyclic ketones useful as tryptase inhibitors
CA2261326A1 (en) 1999-02-09 2000-08-09 Jean-Pascal Viola Laboratory cap and well for hanging-drop crystallization methods
WO2001094332A1 (en) 2000-06-02 2001-12-13 Regents Of The University Of California Profiling of protease specificity using combinatorial fluorogenic substrate libraries

Also Published As

Publication number Publication date
EP1358205A2 (en) 2003-11-05
US6797461B2 (en) 2004-09-28
DE60121225T2 (en) 2007-05-31
ATE331729T1 (en) 2006-07-15
US20020197661A1 (en) 2002-12-26
WO2002034765A3 (en) 2003-08-28
DE60121225D1 (en) 2006-08-10
EP1358205B1 (en) 2006-06-28
WO2002034765A2 (en) 2002-05-02
WO2002034765A9 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
WO1999057325A3 (en) Enzymes mixture
WO1997040141A3 (en) Isolation of enzymes
AU7908598A (en) Alkaline xyloglucanase
WO2002092741A3 (en) 0etergent compositions comprising bacillus subtilis pectate lyases
MXPA04004260A (en) Improved microreplicated surface.
CA2085881A1 (en) Dna encoding mammalian phosphodiesterases
EP2311855A3 (en) Bacillus licheniformis YvnA negative strain
AU2003275613A1 (en) Novel fructosyl peptide oxidase and utilization thereof
WO2004042351A3 (en) Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
WO2004041777A3 (en) Heteroarylpiperidine modulators of chemokine receptor activity
HK1041285A1 (en) Polynucleotide synthesis using a processing enzyme
AU2002365646A1 (en) Novel proteins with il-6 inhibiting activity
NZ514576A (en) Substituted 3-cyano-[1.7], [1.5], and [1.8]- naphthyridine inhibitors of tyrosine kinases
AU2002216613A1 (en) Us0130034idic tryptase substrates and assay for tryptase activity using same
EP0794253A3 (en) Aminopeptidase GX, and a method of hydrolyzing a protein with the same
WO2002093177A3 (en) Assays for identifying modulators of rhomboid polypeptides
EP0896057A3 (en) D-aminoacylase
DE69737457D1 (en) O-fucosyltransferase
AU6700996A (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
EP1161943A3 (en) Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds
WO2001046128A3 (en) Tryptase inhibitors
WO2003020945A3 (en) An enzymatic process for the synthesis of organo-fluorine compounds
WO2000018385A3 (en) Use of acylcarnitines as antitumour agents
WO2002083727A3 (en) Nucleic acid sequences of hyperplasies and tumors of the thyroid
AU2001295005A1 (en) Macromolecules having hydrazide attachment moieties and reagents for their production